Talphera, Inc. (TLPH)
NASDAQ: TLPH · Real-Time Price · USD
0.4199
+0.0104 (2.54%)
Aug 11, 2025, 4:00 PM - Market closed
Paramount Global Market Cap
Talphera has a market cap or net worth of $8.61 million as of August 11, 2025. Its market cap has decreased by -40.61% in one year.
Market Cap
8.61M
Enterprise Value
9.75M
1-Year Change
-40.61%
Ranking
Category
Stock Price
$0.42
Market Cap Chart
Since February 14, 2011, Talphera's market cap has decreased from $84.80M to $8.61M, a decrease of -89.84%. That is a compound annual growth rate of -14.60%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 8, 2025 | 8.40M | -5.62% |
Dec 31, 2024 | 8.90M | -28.80% |
Dec 29, 2023 | 12.50M | -25.60% |
Dec 30, 2022 | 16.80M | -74.85% |
Dec 31, 2021 | 66.80M | -40.46% |
Dec 31, 2020 | 112.20M | -33.17% |
Dec 31, 2019 | 167.90M | 17.41% |
Dec 31, 2018 | 143.00M | 40.33% |
Dec 29, 2017 | 101.90M | -13.57% |
Dec 30, 2016 | 117.90M | -31.09% |
Dec 31, 2015 | 171.10M | -41.84% |
Dec 31, 2014 | 294.20M | -39.56% |
Dec 31, 2013 | 486.80M | 404.46% |
Dec 31, 2012 | 96.50M | 157.33% |
Dec 30, 2011 | 37.50M | -55.78% |
Feb 14, 2011 | 84.80M | - |
View and export this data all the way back to 2011. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 561.67B |
Johnson & Johnson | 417.44B |
AbbVie | 349.87B |
Abbott Laboratories | 233.71B |
AstraZeneca | 227.85B |
UnitedHealth Group | 227.59B |
Novartis AG | 225.61B |
Novo Nordisk | 224.34B |